Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | September 04, 2024 |
| PDB ID | UniProt ID ▼ | Title | Descriptor |
|---|---|---|---|
| 6LZG | P0DTC2 | Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2 | |
| 6M0J | P0DTC2 | Crystal structure of SARS-CoV-2 spike receptor-binding domain bound with ACE2 | |
| 6VXX | P0DTC2 | Structure of the SARS-CoV-2 spike glycoprotein (closed state) | spike glycoprotein |
| 6W41 | P0DTC2 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with human antibody CR3022 | |
| 6WPS | P0DTC2 | Structure of the SARS-CoV-2 spike glycoprotein in complex with the S309 neutralizing antibody Fab fragment | SARS-CoV-2 spike glycoprotein, S309 neutralizing antibody heavy chain, S309 neutralizing antibody light chain |
| 6WPS | P0DTC2 | Structure of the SARS-CoV-2 spike glycoprotein in complex with the S309 neutralizing antibody Fab fragment | SARS-CoV-2 spike glycoprotein, S309 neutralizing antibody heavy chain, S309 neutralizing antibody light chain |
| 6XC2 | P0DTC2 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CC12.1 | |
| 6XC4 | P0DTC2 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CC12.3 | |
| 6XC7 | P0DTC2 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with antibodies CC12.3 and CR3022 | |
| 6ZOZ | P0DTC2 | Structure of Disulphide-stabilized SARS-CoV-2 Spike Protein Trimer (x1 disulphide-bond mutant, S383C, D985C, K986P, V987P, single Arg S1/S2 cleavage site) in Locked State | |
| 6ZWV | P0DTC2 | Cryo-EM structure of SARS-CoV-2 Spike Proteins on intact virions: 3 Closed RBDs | Spike glycoprotein |
| 7A5R | P0DTC2 | Complex of SARS-CoV-2 spike and CR3022 Fab (Non-Uniform Refinement) | CR3022 Fab Heavy Chain, CR3022 Fab Light Chain, Spike glycoprotein |
| 7AKD | P0DTC2 | Structure of the SARS-CoV-2 spike glycoprotein in complex with the 47D11 neutralizing antibody Fab fragment | Spike glycoprotein, 47D11 neutralizing antibody heavy chain, 47D11 neutralizing antibody light chain |
| 7BEI | P0DTC2 | Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with COVOX-150 Fab | |
| 7BEJ | P0DTC2 | Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with COVOX-158 Fab (crystal form 1) | |
| 7BEN | P0DTC2 | Crystal structure of the receptor binding domain of SARS-CoV-2 Spike glycoprotein in a ternary complex with COVOX-253 and COVOX-75 Fabs | |
| 7BNO | P0DTC2 | Open conformation of D614G SARS-CoV-2 spike with 2 Erect RBDs | Spike glycoprotein |
| 7BWJ | P0DTC2 | crystal structure of SARS-CoV-2 antibody with RBD | |
| 7CAB | P0DTC2 | Structural basis for neutralization of SARS-CoV-2 and SARS-CoV by a potent therapeutic antibody | SARS-CoV-2 Spike glycoprotein |
| 7CHH | P0DTC2 | Cryo-EM structure of the SARS-CoV-2 S-6P in complex with BD-368-2 Fabs | Spike glycoprotein, BD-368-2 Fab heavy chain, BD-368-2 Fab light chain |
| 7CM4 | P0DTC2 | Crystal Structure of COVID-19 virus spike receptor-binding domain complexed with a neutralizing antibody CT-P59 | |
| 7D00 | P0DTC2 | S protein of SARS-CoV-2 in complex bound with FabP5A-1B8 | Spike glycoprotein, heavy chain of 4A8, light chain of 4A8 |
| 7DF3 | P0DTC2 | SARS-CoV-2 S trimer, S-closed | Spike glycoprotein |
| 7DF4 | P0DTC2 | SARS-CoV-2 S-ACE2 complex | Angiotensin-converting enzyme 2 (E.C.3.4.17.23,3.4.17.-), Spike glycoprotein |
| 7DK0 | P0DTC2 | Crystal structure of SARS-CoV-2 Spike RBD in complex with MW05 Fab | |
| 7DX2 | P0DTC2 | Trypsin-digested S protein of SARS-CoV-2 D614G mutant | Sodium-dependent neutral amino acid transporter B(0)AT1, Angiotensin-converting enzyme 2 (E.C.3.4.17.23) |
| 7E7D | P0DTC2 | Cryo-EM structure of the SARS-CoV-2 wild-type S-Trimer from a subunit vaccine candidate | |
| 7EAZ | P0DTC2 | Cryo-EM structure of SARS-CoV-2 Spike D614G variant, one RBD-up conformation 1 | |
| 7EDF | P0DTC2 | Cryo-EM structure of SARS-CoV-2 S-UK variant (B.1.1.7), one RBD-up conformation 1 | |
| 7EDJ | P0DTC2 | Cryo-EM structure of SARS-CoV-2 S-UK variant (B.1.1.7) in complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain | |
| 7JJJ | P0DTC2 | Structure of SARS-CoV-2 3Q-2P full-length dimers of spike trimers | Spike glycoprotein |
| 7KDI | P0DTC2 | SARS-CoV-2 D614G 3 RBD down Spike Protein Trimer fully cleaved by furin without the P986-P987 stabilizing mutations (S-RRAR-D614G) | Spike glycoprotein |
| 7KDJ | P0DTC2 | SARS-CoV-2 D614G 1-RBD-up Spike Protein Trimer fully cleaved by furin without the P986-P987 stabilizing mutations (S-RRAR-D614G) | Spike glycoprotein |
| 7KDL | P0DTC2 | SARS-CoV-2 D614G 1-RBD up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G) | Spike glycoprotein |
| 7KEC | P0DTC2 | SARS-CoV-2 D614G 1-RBD-up Spike Protein Trimer without the P986-P987 stabilizing mutations (S-GSAS-D614G Sub-Classification) | Spike glycoprotein |
| 7KFV | P0DTC2 | Structural basis for a germline-biased antibody response to SARS-CoV-2 (RBD:C1A-B12 Fab) | |
| 7KJ3 | P0DTC2 | SARS-CoV-2 Spike Glycoprotein with two ACE2 Bound | Spike glycoprotein |
| 7L2F | P0DTC2 | Cryo-EM structure of NTD-directed neutralizing antibody 5-24 in complex with prefusion SARS-CoV-2 spike glycoprotein | |
| 7L3N | P0DTC2 | SARS-CoV 2 Spike Protein bound to LY-CoV555 | Spike glycoprotein, LY-CoV555 Fab heavy chain, LY-CoV555 Fab light chain |
| 7L56 | P0DTC2 | Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab 2-43 | |
| 7LQW | P0DTC2 | Cryo-EM structure of NTD-directed neutralizing antibody 2-17 Fab in complex with SARS-CoV-2 S2P spike | SARS-CoV-2 spike glycoprotein, neutralizing antibody 2-17 Fab |
| 7LWL | P0DTC2 | Mink Cluster 5-associated SARS-CoV-2 spike protein (S-GSAS-D614G-delFV) in the 3-RBD down conformation | |
| 7LWN | P0DTC2 | Mink Cluster 5-associated SARS-CoV-2 spike protein (S-GSAS-D614G-delFV) in the 1-RBD up conformation | |
| 7LWS | P0DTC2 | UK (B.1.1.7) SARS-CoV-2 S-GSAS-D614G variant spike protein in the 3-RBD-down conformation | Spike glycoprotein |
| 7LWV | P0DTC2 | UK (B.1.1.7) SARS-CoV-2 spike protein variant (S-GSAS-B.1.1.7) in the 1-RBD-up conformation | |
| 7LXY | P0DTC2 | SARS-CoV-2 S/S2M11/S2X333 Global Refinement | Spike glycoprotein, S2M11 Fab Light Chain variable region, S2M11 Fab Heavy Chain variable region, S2X333 Fab Heavy Chain variable region, S2X333 Fab Light Chain variable region |
| 7LYN | P0DTC2 | South African (B.1.351) SARS-CoV-2 spike protein variant (S-GSAS-B.1.351) in the 1-RBD-up conformation | |
| 7LYO | P0DTC2 | South African (B.1.351) SARS-CoV-2 spike protein variant (S-GSAS-B.1.351) in the 1-RBD-up conformation | |
| 7M6F | P0DTC2 | Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, BG1-22 | Spike glycoprotein, BG1-22 Fab Heavy Chain, BG1-22 Fab Light Chain |
| 7M6G | P0DTC2 | Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, BG7-15 | Spike glycoprotein, BG7-15 Fab Heavy Chain, BG7-15 Fab Light Chain |
